UnitedHealth Group Inc. - Q1 2005 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2005. UnitedHealth Group Inc. operates through four primary segments: Health Care Services (UnitedHealthcare, Ovations, AmeriChoice), Uniprise, Specialized Care Services, and Ingenix. The reporting period includes the full impact of the 2004 acquisitions of Oxford Health Plans and Mid Atlantic Medical Services (MAMSI), as well as the December 2004 acquisition of Definity Health Corporation.
Key Financial Metrics
| Metric | Q1 2005 | Q1 2004 |
|---|---|---|
| Total Revenues | $10,887 million | $8,144 million |
| Net Earnings | $779 million | $554 million |
| Diluted EPS | $1.16 | $0.88 |
| Operating Cash Flow | $1,206 million | $910 million |
| Medical Care Ratio | 80.1% | 80.8% |
| Operating Margin | 11.5% | 10.8% |
| Total Debt (Carrying Value) | $4,250 million | $4,023 million |
| Cash & Investments | $12,563 million | $10,990 million (approx.) |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 34% year-over-year. Excluding acquisitions, organic revenue growth was approximately 11%, driven by rate increases and enrollment growth.
- Profitability: Net earnings rose 41% to $779 million. Earnings from operations increased 43% to $1.256 billion.
- Cost Management: The Medical Care Ratio improved to 80.1% (down from 80.8%), aided by $190 million in favorable medical cost development from prior periods. The Operating Cost Ratio improved to 14.9% from 16.2%.
- Capital Allocation: The company repurchased 13.2 million shares of common stock for approximately $1.2 billion during the quarter. In March 2005, the company issued $500 million in 4.9% fixed-rate notes due 2015.
Outlook, Risks, and Unusual Items
- Subsequent Event: On May 3, 2005, the Board declared a two-for-one stock split effective May 27, 2005. The annual cash dividend rate will effectively double to maintain the 3-cent per share post-split rate.
- Accounting Changes: The company is evaluating the impact of FAS No. 123(R) regarding share-based payments, effective Q1 2006. Pro forma net earnings for Q1 2005 would have been $743 million under this standard.
- Legal Proceedings: Significant litigation includes the "In Re: Managed Care Litigation" (MDL No. 1334) with a trial date set for September 2005, and a lawsuit by the American Medical Association regarding reimbursement rates. Management does not believe these will have a material adverse effect.
- Risks: Key risks include the ability to accurately predict medical cost trends (a 1% increase in commercial medical costs could reduce annual net earnings by ~$105 million), regulatory changes (Medicare Modernization Act), and the integrity of information systems.
Investor Verification Checklist
- Acquisition Integration: Verify the ongoing integration and performance of Oxford Health Plans and MAMSI, which drove the majority of revenue growth.
- Medical Cost Estimates: Monitor the $190 million favorable development in medical costs; assess the sustainability of this trend against inflation and utilization rates.
- Stock Split Impact: Confirm the mechanics of the two-for-one stock split and the adjusted dividend rate.
- Debt Covenants: Verify continued compliance with the debt-to-total-capital ratio covenant (currently 28.7%, well below the 45% limit).
- Legal Exposure: Track the September 2005 trial date for the MDL No. 1334 class action lawsuit.